| Literature DB >> 35785061 |
Wenlei Xia1, Xiaofang Chen1,2, Guangming Wang1.
Abstract
Exploring the impact of a new round of mixed-ownership reform on enterprise development has far-reaching implications for the future development of mixed-ownership reform and the improvement of internal and external corporate governance of the enterprise. This study makes a comprehensive analysis of the relationship between mixed-ownership reform and innovation performance using a combination of empirical testing and theoretical analysis. In terms of theoretical analysis, this study summarizes research on mixed-ownership reform and innovation performance, while also integrating the theoretical basis of the development and institutional background of China's current mixed-ownership reform, and investigating the impact of mixed-ownership reform on innovation performance. A-share list of manufacturing companies from 2015 to 2018 is selected as the research object, and K-nearest neighbor matching, multiple regression model, and propensity score matching are used to test the effect of mixed-ownership reform on innovation performance. By comparing the changes in the innovation performance level of state-owned enterprises (SOEs) before and after the mixed-ownership reform, this study proposes that the SOEs will not only enhance the competitiveness among manufacturing companies but also will have a positive impact on the high-quality development of the entire society and industrial transformation and upgrading.Entities:
Mesh:
Year: 2022 PMID: 35785061 PMCID: PMC9249442 DOI: 10.1155/2022/3809829
Source DB: PubMed Journal: Comput Intell Neurosci
Figure 1The impact path of mixed-ownership reform on innovation performance.
Variable definitions.
| Type of variable | Variable name | Variable code | Variable meaning |
|---|---|---|---|
| Dependent variable (enterprise innovation performance evaluation index) | Innovation input | Lnrdspend | The logarithm of |
| Innovation output | Lnpatents | Add 1 to the number of patent applications in the year to take the natural logarithm | |
|
| |||
| Independent variable | Mixed ownership reform | Reform | 0 for unreformed firms and 1 for reformed firms |
| Time variable | Time | 0 before the reform, 1 after the reform | |
|
| |||
| Control variable | Company size | Inside | Logarithm of total assets |
| Financial leverage | Lev | Assets and liabilities | |
| Two-job situation | Dual | The combination of chairman and general manager takes 1; otherwise, it is 0. | |
| Market competition | Compete | Selling expenses/operating income | |
| The proportion of independent directors | Indratio | Number of independent directors/board size | |
| Return on assets | Roa | Return on total assets (net profit/total average assets) | |
| Operating net profit margin | Opr | Net profit/operating income | |
| Number of employees | Lnlabor | The natural logarithm of the number of employees | |
| Ownership concentration | Concern | The Herfindahl coefficient of the shareholding ratio of the largest shareholder | |
| Fixed asset investment | Rta | Net fixed assets/total assets | |
| Year | Year | Year of the company | |
Variable descriptive statistics of all samples.
| Variable | Observations | Average value | Standard deviation | Minimum | Maximum |
|---|---|---|---|---|---|
| Lnrdspend | 1120 | 18.205. | 1.343 | 14.214 | 22.060 |
| Inpatents | 720 | 2.718 | 1.289 | 0 | 5.760 |
| Reform | 1120 | 0.629 | 0.501 | 0 | 1 |
| Lnsize | 1120 | 23.478 | 1.126 | 20.190 | 26.893 |
| Lev | 1120 | 0.478 | 0.193 | 0.079 | 0.863 |
| Dual | 1120 | 0.664 | 0.472 | 0 | 0.368 |
| Roe | 1120 | 0.193 | 2.590 | −0.452 | 0.329 |
| Compete | 1120 | 0.076 | 0.070 | 0.011 | 0.571 |
| Indratio | 1120 | 0.463 | 0.063 | 0.333 | 0.382 |
| Roa | 1120 | 0.030 | 0.107 | −0.391 | 0.24 |
| Opr | 1120 | 0.086 | 0.243 | −0.493 | 10.692 |
| Lnlabor | 1120 | 9.092 | 1.182 | 5.280 | 0.682 |
| Concern | 1120 | 0.269 | 0.153 | 0.014. | 0.656 |
| Rta | 1120 | 0.365 | 0.178 | 0.091 | 22.060 |
Descriptive statistics of variables in the sample of reformed enterprises.
| Variable | Observations | Average value | Standard deviation | Minimum | Maximum |
|---|---|---|---|---|---|
| Lnrdspend | 704 | 18.36 | 1.489 | 14.214 | 21.773 |
| Lnpatents | 472 | 2.44 | 1.452 | 0 | 4.780 |
| Time | 704 | 0.703 | 0.464 | −5.760 | 0.992 |
| Lnsize: | 704 | 22.258 | 1.293 | 0.079 | 0.862. |
| Lev | 704 | 0.476 | 0.201 | −0.452 | 0.367 |
| Dual | 704 | 0.685 | 0.453 | 0.011 | 0.325 |
| Roe | 704 | 0.109 | 2.020 | 0.333 | 0.563 |
| Compete | 704 | 0.071 | 0.063 | −0.376 | 0.382 |
| Indratio | 704 | 0.472 | 0.063 | −0.493 | 0.22 |
| Roa | 704 | 0.028. | 0.112 | 5.280 | 10.692 |
| Opr | 704 | 0.054 | 0.225 | 0.014 | 0.681. |
| Lnlabor | 704 | 8.916 | 1.195 | 0.091 | 0.656. |
Innovation input matching balance test.
| Mean |
| ||||||
|---|---|---|---|---|---|---|---|
| Variable name | Deal with | Treatment group | Control group | Standard deviation (%) | Difference |
|
|
| Lnsize | Before match | 23.119 | 22.751 | 29.3 | 76.1 | 2.09 | 0.037 |
| After matching | 23.119 | 23.207 | −7.0 | −0.38 | 0.701 | ||
|
| |||||||
| Dual | Before match | 0.93662 | 0.87069 | 22.4 | 100.0 | 1.82 | 0.070 |
| After matching | 1 | 1 | 0.0 | 0.00. | 1.000 | ||
|
| |||||||
| Lev | Before match | 0.47804 | 0.4489 | 15.1 | 79.6 | 1.21 | 0.226 |
| After matching | 0.46696. | 0.46101 | 3.1 | 0.15 | 0.881 | ||
|
| |||||||
| Opr | Before match | 0.05221 | 0.01781 | 28.2 | 75.3 | 2.24 | 0.026 |
| After matching | 0.03239 | 0.04088 | −7.0 | −0.44 | 0.661 | ||
|
| |||||||
| Roa | Before match | 0.03657 | 0.02246. | 25.6 | 98.8 | 2.01 | 0.045 |
| After matching | 0.02646 | 0.02663 | −0.3 | −0.02 | 0.985 | ||
Innovation output matching balance test.
| Mean |
| ||||||
|---|---|---|---|---|---|---|---|
| Variable name | Deal with | Treatment group | Control group | Standard deviation (%) | Difference |
|
|
| Lnsize | Before match | 22.444 | 21.826 | 68.0 | 99.5 | 5.15 | 0.000 |
| After matching | 22.444 | 22.447 | −0.4 | −0.02 | 0.984 | ||
|
| |||||||
| Dual | Before match | 0.92308 | 0.63008 | 75.0 | 99.5 | 4.85 | 0.000 |
| After matching | 0.92308 | 0.92462 | −0.4 | −0.03. | 0.974 | ||
|
| |||||||
| Lev | Before match | 0.4694 | 0.34977 | 69.8 | 92.0 | 5.54 | 0.000 |
| After matching | 0.4694 | 0.45979 | 5.6 | 0.34 | 0.737 | ||
|
| |||||||
| Opr | Before match | 0.05604 | 0.09669 | −36.7 | 79.0 | −2.52 | 0.012 |
| After matching | 0.05604 | 0.04748 | 7.7 | 0.32 | 0.752 | ||
|
| |||||||
| Roa | Before match | 0.03787 | 0.05036 | −23.1 | 69.9 | 0.31 | 0.109 |
| After matching | 0.03787 | 0.03412 | −6.9. | 5.15 | 0.755 | ||
Estimated results.
| Variable name | Sample | Treatment group | Control group | Difference | Standard deviation |
|
|---|---|---|---|---|---|---|
| Lnrdspend | After matching (ATT) | 18.343 | 17.746 | 0.597 | 0.282 | 2.11 |
| Lnpatents | After matching (ATT) | 4.697 | 4.345 | 0.352 | 0.172 | 2.04 |